WallStreetZenWallStreetZen

NASDAQ: SXTC
China Sxt Pharmaceuticals Inc Stock Ownership - Who owns China Sxt Pharmaceuticals?

Insider buying vs selling

Have China Sxt Pharmaceuticals Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when SXTC insiders and whales buy or sell their stock.

SXTC Shareholders

What type of owners hold China Sxt Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Acadian Asset Management LLC0.38%2,759$2.95kInstitution
Qube Research Technologies Ltd0.01%103$110.21Institution
Ubs Group Ag0.00%8$8.56Institution
Banque Cantonale Vaudoise0.00%1$1.07Institution
Concourse Financial Group Securities Inc0.00%0$0.00Institution

1 of 1

SXTC vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SXTC0.39%0.00%
PRFX9.63%0.00%
AKAN85.73%0.00%
LSDI6.76%93.24%
YCBD0.27%99.73%

China Sxt Pharmaceuticals Stock Ownership FAQ

Who owns China Sxt Pharmaceuticals?

China Sxt Pharmaceuticals (NASDAQ: SXTC) is owned by 0.39% institutional shareholders, 0.00% China Sxt Pharmaceuticals insiders, and 99.61% retail investors. Acadian Asset Management LLC is the largest individual China Sxt Pharmaceuticals shareholder, owning 2759.00 shares representing 0.38% of the company. Acadian Asset Management LLC's China Sxt Pharmaceuticals shares are currently valued at $2.98k.

If you're new to stock investing, here's how to buy China Sxt Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.